Nexien BioPharma, Inc. (NXEN)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -64.36 Thousand | -81.75 Thousand | -75.14 Thousand | -90.74 Thousand | -147.57 Thousand | -643.38 Thousand |
| Net Income | -239.11 Thousand | -361.9 Thousand | -626.35 Thousand | -1.85 Million | -2.67 Million | -4.3 Million |
| Depreciation & Amortization | - | 49.76 Thousand | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 203 Thousand | 379 Thousand | 348.95 Thousand | 52.13 Thousand | 1.89 Million |
| Change in working capital | 37.51 Thousand | 2888.00 | 13.9 Thousand | 7385.00 | 35.54 Thousand | -92.18 Thousand |
| Other non-cash items | 137.23 Thousand | 277.06 Thousand | 536.93 Thousand | 1.41 Million | 2.43 Million | 1.85 Million |
| Investing Cash Flow | - | - | - | - | - | -30 Thousand |
| Investments in PPE | 4.00 | - | - | - | - | -30 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -30.00 |
| Financing Cash Flow | 33.4 Thousand | - | 174 Thousand | 98 Thousand | 12 Thousand | - |
| Debt repayment | -20 Thousand | - | -146.75 Thousand | -78 Thousand | -12 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2250.00 | - | - | - |
| Other Financing Activities | 13.4 Thousand | - | 318.5 Thousand | 176 Thousand | 24 Thousand | - |
| Accounts receivables | - | - | - | - | - | 15 Thousand |
| Accounts payables | 29.53 Thousand | 3248.00 | 14.02 Thousand | 2885.00 | -26.09 Thousand | -42.53 Thousand |
| Inventory | - | - | - | - | - | -1.00 |
| Other working capital | 37.51 Thousand | -360.00 | -120.00 | 4500.00 | 61.64 Thousand | -64.64 Thousand |
| Cash at beginning of period | 35.14 Thousand | 116.89 Thousand | 18.04 Thousand | 10.78 Thousand | 146.35 Thousand | 819.73 Thousand |
| Cash at end of period | 4183.00 | 35.14 Thousand | 116.89 Thousand | 18.04 Thousand | 10.78 Thousand | 146.35 Thousand |
| Capital Expenditure | 4.00 | - | - | - | - | -30 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -30.96 Thousand | -81.75 Thousand | 98.85 Thousand | 7255.00 | -135.57 Thousand | -673.38 Thousand |
| Free Cash Flow | -64.36 Thousand | -81.75 Thousand | -75.14 Thousand | -90.74 Thousand | -147.57 Thousand | -673.38 Thousand |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -86.51 Thousand | -53.16 Thousand | -24.51 Thousand | -74.91 Thousand | -361.9 Thousand | -93.58 Thousand |
| Depreciation & Amortization | - | 6.18 | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 35.00 | 203 Thousand | 50.75 |
| Change in working capital | 12.85 Thousand | 3968.00 | 4387.00 | 16.3 Thousand | 2888.00 | -2754.00 |
| Other non-cash items | 62.77 Thousand | 20.07 Thousand | 4686.00 | 41.49 Thousand | 277.06 Thousand | 77.22 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5000.00 | 28.4 Thousand | - | - | - | - |
| Debt repayment | -33.4 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5000.00 | 28.40 | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 8652.00 | 8168.00 | 397.00 | 12.31 Thousand | 3248.00 | 1236.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 12.85 Thousand | -4200.00 | 3990.00 | 3990.00 | -360.00 | -3990.00 |
| Cash at beginning of period | 10.06 Thousand | 2619.00 | 18.06 Thousand | 35.14 Thousand | 116.89 Thousand | 54.2 Thousand |
| Cash at end of period | 4183.00 | 10.06 Thousand | 2619.00 | 18.06 Thousand | 35.14 Thousand | 35.14 Thousand |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5884.00 | 7448.00 | -15.44 Thousand | -17.08 Thousand | -81.75 Thousand | -19.06 Thousand |
| Free Cash Flow | -10.88 Thousand | -20.95 Thousand | -15.44 Thousand | -17.08 Thousand | -81.75 Thousand | -19.06 Thousand |
5918
BRKWF
TRMLF
JEXYY
PATELSAI
0HD0